definiens: mean ( a ) any single product comprising both ( i ) a Licensed Compound ( or HER2 Trident Product, Margetuximab Product or M GD013 Product ) and ( ii ) one or more other therapies or pharmaceutically active compounds or substances tha t is not a Licensed Compound ; ( b ) any sale of a Pro duct with another therapy(ies ) or product(s ) for a single inv oice price ; or ( c ) any sale of a Product as part of a bundle with other therapy(ies ), product(s ) or service(s ) ( i.e., where a Product and such other therapy(ies ), produ ct(s ) or service(s ) are sold for a single invoice price or w here a discount, rebate or other amount that reduce s the price of a Product is provided in exchange for ( or otherwise conditioned upon ) the purchase of such other thera py(ies ), product(s ) or services ), to the extent not describe d in clause ( a ) or ( b ) . The Licensed Compound ( or H ER2 Trident Product, Margetuximab Product or MGD013 Product ) po rtion of any Combination Product shall be deemed th e and the other portion of such Combination Product ( including MGA012 or any other product Controlled by [COMPANY] with respect to C ombination Regimens ) shall be deemed the, and each Combination Product shall be deemed a P roduct hereunder